| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
All Oral HCV Therapies of the Future
|
Kumar, Sonal
|
|
|
12 |
4 |
p. 214-219
|
artikel
|
| 2 |
All Oral HCV Therapies of the Future
|
Kumar, Sonal
|
|
2013
|
12 |
4 |
p. 214-219
|
artikel
|
| 3 |
Current and Future Treatment of Chronic Hepatitis C Genotype 2 and 3
|
Hoener zu Siederdissen, Christoph
|
|
2013
|
12 |
4 |
p. 261-268
|
artikel
|
| 4 |
IL28B Polymorphisms Among Latin American HCV Patients
|
Soza, Alejandro
|
|
2013
|
12 |
4 |
p. 276-279
|
artikel
|
| 5 |
Implementation and Impact of HAV and HBV Vaccination Programs in South America
|
Paraná, Raymundo
|
|
2013
|
12 |
4 |
p. 305-311
|
artikel
|
| 6 |
Is There a Need for Cluster Hepatitis B and C Epidemiological Studies in the Region?: Yes
|
Insua, Jorge T.
|
|
2013
|
12 |
4 |
p. 288-296
|
artikel
|
| 7 |
Is There a Need for Cluster Hepatitis B and C Epidemiological Studies in the Region?: Yes
|
Insua, Jorge T.
|
|
|
12 |
4 |
p. 288-296
|
artikel
|
| 8 |
Limited Access to Protease Inhibitors Therapy for Chronic HCV in the Region: YES
|
Méndez, Julio Castro
|
|
2013
|
12 |
4 |
p. 280-287
|
artikel
|
| 9 |
Limited Access to Protease Inhibitors Therapy for Chronic HCV in the Region: YES
|
Méndez, Julio Castro
|
|
|
12 |
4 |
p. 280-287
|
artikel
|
| 10 |
Natural History of HCV-induced Liver Disease
|
Meer, Adriaan J. van der
|
|
2013
|
12 |
4 |
p. 251-260
|
artikel
|
| 11 |
New Insights in the Diagnosis, Pathogenesis and Treatment of Hepatitis B- and C-related Hepatocellular Carcinoma
|
Aguilar-Olivos, Nancy
|
|
2013
|
12 |
4 |
p. 297-304
|
artikel
|
| 12 |
Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
|
Gerold, Gisa
|
|
2013
|
12 |
4 |
p. 200-213
|
artikel
|
| 13 |
Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
|
Gerold, Gisa
|
|
|
12 |
4 |
p. 200-213
|
artikel
|
| 14 |
Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation
|
Price, Jennifer C.
|
|
2013
|
12 |
4 |
p. 227-235
|
artikel
|
| 15 |
Real World Experience in the Era of First Generation Protease Inhibitors in the Treatment of Hepatitis C
|
Hubbard, Hope
|
|
|
12 |
4 |
p. 189-194
|
artikel
|
| 16 |
Real World Experience in the Era of First Generation Protease Inhibitors in the Treatment of Hepatitis C
|
Hubbard, Hope
|
|
2013
|
12 |
4 |
p. 189-194
|
artikel
|
| 17 |
Relevance of Resistance Against Direct Acting Antiviral Agents in Hepatitis C Virus Infection – What Technology do we Really Need in Clinical Practice?
|
Ciesek, Sandra
|
|
2013
|
12 |
4 |
p. 195-199
|
artikel
|
| 18 |
The Role of Public Health in an Era of All-Oral Therapy for Hepatitis C Infection
|
Ward, John W.
|
|
2013
|
12 |
4 |
p. 220-226
|
artikel
|
| 19 |
Treatment of Chronic Hepatitis C, Genotype 4
|
Ferenci, Peter
|
|
2013
|
12 |
4 |
p. 246-250
|
artikel
|
| 20 |
Treatment of Hepatitis C in HIV Patients in the New Era of Direct-Acting Antivirals
|
Fernández-Montero, José Vicente
|
|
|
12 |
4 |
p. 269-275
|
artikel
|
| 21 |
Treatment of Hepatitis C in HIV Patients in the New Era of Direct-Acting Antivirals
|
Fernández-Montero, José Vicente
|
|
2013
|
12 |
4 |
p. 269-275
|
artikel
|
| 22 |
Treatment of Hepatitis C in the Patient with Decompensated Cirrhosis
|
Everson, Gregory T.
|
|
|
12 |
4 |
p. 236-245
|
artikel
|
| 23 |
Treatment of Hepatitis C in the Patient with Decompensated Cirrhosis
|
Everson, Gregory T.
|
|
2013
|
12 |
4 |
p. 236-245
|
artikel
|
| 24 |
Update on HIV and Hepatitis Virus Coinfection: The South American Perspective
|
Fainboim, H.
|
|
|
12 |
4 |
p. 312-319
|
artikel
|
| 25 |
Update on HIV and Hepatitis Virus Coinfection: The South American Perspective
|
Fainboim, H.
|
|
2013
|
12 |
4 |
p. 312-319
|
artikel
|
Tijdschrift beschrijving